Literature DB >> 12596228

Molecular architecture of intermediate filaments.

Sergei V Strelkov1, Harald Herrmann, Ueli Aebi.   

Abstract

Together with microtubules and actin microfilaments, approximately 11 nm wide intermediate filaments (IFs) constitute the integrated, dynamic filament network present in the cytoplasm of metazoan cells. This network is critically involved in division, motility and other cellular processes. While the structures of microtubules and microfilaments are known in atomic detail, IF architecture is presently much less understood. The elementary 'building block' of IFs is a highly elongated, rod-like dimer based on an alpha-helical coiled-coil structure. Assembly of cytoplasmic IF proteins, such as vimentin, begins with a lateral association of dimers into tetramers and gradually into the so-called unit-length filaments (ULFs). Subsequently ULFs start to anneal longitudinally, ultimately yielding mature IFs after a compaction step. For nuclear lamins, however, assembly starts with a head-to-tail association of dimers. Recently, X-ray crystallographic data were obtained for several fragments of the vimentin dimer. Based on the dimer structure, molecular models of the tetramer and the entire filament are now a possibility. Copyright 2003 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2003        PMID: 12596228     DOI: 10.1002/bies.10246

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  60 in total

1.  Biochemical and immunological characterization of pea nuclear intermediate filament proteins.

Authors:  Sonal S D Blumenthal; Gregory B Clark; Stanley J Roux
Journal:  Planta       Date:  2004-01-15       Impact factor: 4.116

2.  The intermediate filament architecture as determined by X-ray diffraction modeling of hard alpha-keratin.

Authors:  Meriem Er Rafik; Jean Doucet; Fatma Briki
Journal:  Biophys J       Date:  2004-06       Impact factor: 4.033

3.  Identification of novel principles of keratin filament network turnover in living cells.

Authors:  Reinhard Windoffer; Stefan Wöll; Pavel Strnad; Rudolf E Leube
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

4.  Microtubule-dependent transport of vimentin filament precursors is regulated by actin and by the concerted action of Rho- and p21-activated kinases.

Authors:  Amélie Robert; Harald Herrmann; Michael W Davidson; Vladimir I Gelfand
Journal:  FASEB J       Date:  2014-03-20       Impact factor: 5.191

5.  Characterization of the linker 2 region in human vimentin using site-directed spin labeling and electron paramagnetic resonance.

Authors:  John F Hess; Madhu S Budamagunta; Rebecca L Shipman; Paul G FitzGerald; John C Voss
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

Review 6.  A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers.

Authors:  M Guthold; W Liu; E A Sparks; L M Jawerth; L Peng; M Falvo; R Superfine; R R Hantgan; S T Lord
Journal:  Cell Biochem Biophys       Date:  2007-10-02       Impact factor: 2.194

Review 7.  Deformation and failure of protein materials in physiologically extreme conditions and disease.

Authors:  Markus J Buehler; Yu Ching Yung
Journal:  Nat Mater       Date:  2009-03       Impact factor: 43.841

Review 8.  Intermediate filaments: primary determinants of cell architecture and plasticity.

Authors:  Harald Herrmann; Sergei V Strelkov; Peter Burkhard; Ueli Aebi
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 9.  Cytoskeleton as a potential target in the neuropathology of maple syrup urine disease: insight from animal studies.

Authors:  R Pessoa-Pureur; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

10.  Microfilaments and microtubules alternately coordinate the multi-step endosomal trafficking of Classical Swine Fever Virus.

Authors:  Yan Cheng; Jin-Xiu Lou; Chun-Chun Liu; Ya-Yun Liu; Xiong-Nan Chen; Xiao-Dong Liang; Jin Zhang; Qian Yang; Yun Young Go; Bin Zhou
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.